Editor's note: Seeking Alpha is proud to welcome Kailyn Hui as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
Genfit (GNFTF) is a biopharmaceutical company specializing in the discovery and development of therapeutic and diagnostic solutions in the area of metabolic, inflammatory, autoimmune and fibrotic diseases, in particular liver and gastrointestinal diseases. The company's pipeline includes Elafibranor (NASH, PBC), NASH diagnostic biomarkers program (BMGFT03),